Room A ESMO Colloquium
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Location
Room A
Chairs
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Introduction

Lecture Time
11:45 - 11:50
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

First-line immunotherapy options for patients without an oncogene driver

Lecture Time
11:50 - 12:10
Speakers
  • R. Califano (Manchester, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • R. Califano (Manchester, United Kingdom)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

What is the biological rationale for combining chemotherapy with immune checkpoint inhibitors?

Lecture Time
12:10 - 12:30
Speakers
  • M. Garassino (Milan, Italy)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • M. Garassino (Milan, Italy)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Are immune checkpoints (ICPs) better as single agent, doublet ICPs or combined with chemo +/- anti-angiogenics?

Lecture Time
12:30 - 12:50
Speakers
  • S. Peters (Lausanne, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • S. Peters (Lausanne, Switzerland)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Recommendation on second-line treatment according to first-line choice

Lecture Time
12:50 - 13:10
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)
ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Conclusion

Lecture Time
13:10 - 13:15
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)